SLCO1B1 variants and urine arsenic metabolites in the strong heart family study

Toxicological Sciences

Volumn 136, Issue 1, 2013, Pages 19-25

  Gribble, Matthew O ^a,g   Voruganti, Venkata Saroja ^b   Cropp, Cheryl D ^c   Francesconi, Kevin A ^d   Goessler, Walter ^d   Umans, Jason G ^e,f   Silbergeld, Ellen K ^a   Laston, Sandra L ^b   Haack, Karin ^c   Kao, Wen Hong Linda ^a   Fallin, Margaret Daniele ^a   Maccluer, Jean W ^b   Cole, Shelley A ^b   Navas Acien, Ana ^a,g  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

^c NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF GRAZ   (Austria)

^e MEDSTAR RESEARCH INSTITUTE   (United States)

^f Delaware   (United States)

^g JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

American Indians; Arsenic metabolism; Arsenic species; OATPC; SLCO1B1; Strong heart study

Indexed keywords

ARSENIC DERIVATIVE; ORGANIC ANION TRANSPORTER 2;

ADULT; ARTICLE; BODY MASS; FAMILY STUDY; GENE FREQUENCY; GENETIC VARIABILITY; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; METABOLITE; POPULATION GENETICS; SEX; SINGLE NUCLEOTIDE POLYMORPHISM; URINE;

AMERICAN INDIANS; ARSENIC METABOLISM; ARSENIC SPECIES; OATPC; SLCO1B1; STRONG HEART STUDY.;

ARSENIC; ARSENICALS; BIOLOGICAL MARKERS; BIOTRANSFORMATION; CACODYLIC ACID; CARDIOVASCULAR DISEASES; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; HETEROZYGOTE; HOMOZYGOTE; HUMANS; INDIANS, NORTH AMERICAN; LINEAR MODELS; MALE; ORGANIC ANION TRANSPORTERS; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; UNITED STATES; WATER POLLUTANTS, CHEMICAL;

EID: 84887987668     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kft181     Document Type: Article

References (68)

1. Abecasis, G. R., Cardon, L. R., and Cookson, W. O. (2000a). A general test of association for quantitative traits in nuclear families. Am. J. Hum. Genet. 66, 279-292.
2. Abecasis, G. R., Cookson, W. O., and Cardon, L. R. (2000b). Pedigree tests of transmission disequilibrium. Eur. J. Hum. Genet. 8, 545-551.
3. Achour, A. R., Bauda, P., and Billard, P. (2007). Diversity of arsenite transporter genes from arsenic-resistant soil bacteria. Res. Microbiol. 158, 128-137.
4. Ahsan, H., Chen, Y., Parvez, F., Argos, M., Hussain, A. I., Momotaj, H., Levy, D., van Geen, A., Howe, G., and Graziano, J. (2006). Health Effects of Arsenic Longitudinal Study (HEALS): Description of a multidisciplinary epidemiologic investigation. J. Expo. Sci. Environ. Epidemiol. 16, 191-205.
5. Almasy, L., and Blangero, J. (1998). Multipoint quantitative-trait linkage analysis in general pedigrees. Am. J. Hum. Genet. 62, 1198-1211.
6. Boerwinkle, E., Chakraborty, R., and Sing, C. F. (1986). The use of measured genotype information in the analysis of quantitative phenotypes in man. I. Models and analytical methods. Ann. Hum. Genet. 50(Pt 2), 181-194.
7. Briat, J. F. (2010). Arsenic tolerance in plants: "Pas de deux" between phytochelatin synthesis and ABCC vacuolar transporters. Proc. Natl. Acad. Sci. U.S.A. 107, 20853-20854.
8. Calatayud, M., Barrios, J. A., Velez, D., and Devesa, V. (2012). In vitro study of transporters involved in intestinal absorption of inorganic arsenic. Chem. Res. Toxicol. 25, 446-453.
9. Calatayud, M., Gimeno, J., Vélez, D., Devesa, V., and Montoro, R. (2010). Characterization of the intestinal absorption of arsenate, monomethylarsonic acid, and dimethylarsinic acid using the Caco-2 cell line. Chem. Res. Toxicol. 23, 547-556.
10. Carbrey, J. M., Song, L., Zhou, Y., Yoshinaga, M., Rojek, A., Wang, Y., Liu, Y., Lujan, H. L., DiCarlo, S. E., Nielsen, S., et al. (2009). Reduced arsenic clearance and increased toxicity in aquaglyceroporin-9-null mice. Proc. Natl. Acad. Sci. U.S.A. 106, 15956-15960.
11. Carew, M. W., and Leslie, E. M. (2010). Selenium-dependent and -independent transport of arsenic by the human multidrug resistance protein 2 (MRP2/ ABCC2): Implications for the mutual detoxification of arsenic and selenium. Carcinogenesis 31, 1450-1455.
12. Catarecha, P., Segura, M. D., Franco-Zorrilla, J. M., García-Ponce, B., Lanza, M., Solano, R., Paz-Ares, J., and Leyva, A. (2007). A mutant of the Arabidopsis phosphate transporter PHT1;1 displays enhanced arsenic accumulation. Plant Cell 19, 1123-1133.
13. Chavan, H., Oruganti, M., and Krishnamurthy, P. (2011). The ATP-binding cassette transporter ABCB6 is induced by arsenic and protects against arsenic cytotoxicity. Toxicol. Sci. 120, 519-528.
14. Chen, Y. C., Guo, Y. L., Su, H. J., Hsueh, Y. M., Smith, T. J., Ryan, L. M., Lee, M. S., Chao, S. C., Lee, J. Y., and Christiani, D. C. (2003a). Arsenic methylation and skin cancer risk in southwestern Taiwan. J. Occup. Environ. Med. 45, 241-248.
15. Chen, Y. C., Su, H. J., Guo, Y. L., Hsueh, Y. M., Smith, T. J., Ryan, L. M., Lee, M. S., and Christiani, D. C. (2003b). Arsenic methylation and bladder cancer risk in Taiwan. Cancer Cause Control 14, 303-310.
16. Cutler, M. J., and Choo, E. F. (2011). Overview of SLC22A and SLCO families of drug uptake transporters in the context of cancer treatments. Curr. Drug Metab. 12, 793-807.
17. Drobná, Z., Walton, F. S., Paul, D. S., Xing, W., Thomas, D. J., and Stỳblo, M. (2010). Metabolism of arsenic in human liver: The role of membrane transporters. Arch. Toxicol. 84, 3-16.
18. Engström, K., Vahter, M., Mlakar, S. J., Concha, G., Nermell, B., Raqib, R., Cardozo, A., and Broberg, K. (2011). Polymorphisms in arsenic(+III oxidation state) methyltransferase (AS3MT) predict gene expression of AS3MT as well as arsenic metabolism. Environ. Health Perspect. 119, 182-188.
19. Engström, K. S., Hossain, M. B., Lauss, M., Ahmed, S., Raqib, R., Vahter, M., and Broberg, K. (2013). Efficient arsenic metabolism-the AS3MT haplotype is associated with DNA methylation and expression of multiple genes around AS3MT. PLoS One 8, e53732.
20. Epel, D., Luckenbach, T., Stevenson, C. N., Macmanus-Spencer, L. A., Hamdoun, A., and Smital, T. (2008). Efflux transporters: Newly appreciated roles in protection against pollutants. Environ. Sci. Technol. 42, 3914-3920.
21. Fujihara, J., Fujii, Y., Agusa, T., Kunito, T., Yasuda, T., Moritani, T., and Takeshita, H. (2009). Ethnic differences in five intronic polymorphisms associated with arsenic metabolism within human arsenic (+3 oxidation state) methyltransferase (AS3MT) gene. Toxicol. Appl. Pharmacol. 234, 41-46.
22. Fujihara, J., Kunito, T., Agusa, T., Yasuda, T., Iida, R., Fujii, Y., and Takeshita, H. (2007). Population differences in the human arsenic (+3 oxidation state) methyltransferase (AS3MT) gene polymorphism detected by using genotyping method. Toxicol. Appl. Pharmacol. 225, 251-254.
23. Fujihara, J., Soejima, M., Koda, Y., Kunito, T., and Takeshita, H. (2008). Asian specific low mutation frequencies of the M287T polymorphism in the human arsenic (+3 oxidation state) methyltransferase (AS3MT) gene. Mutat. Res. 654, 158-161.
24. Fujihara, J., Soejima, M., Yasuda, T., Koda, Y., Agusa, T., Kunito, T., Tongu, M., Yamada, T., and Takeshita, H. (2010). Global analysis of genetic variation in human arsenic (+3 oxidation state) methyltransferase (AS3MT). Toxicol. Appl. Pharmacol. 243, 292-299.
25. Fujihara, J., Yasuda, T., Kato, H., Yuasa, I., Panduro, A., Kunito, T., and Takeshita, H. (2011). Genetic variants associated with arsenic metabolism within human arsenic (+3 oxidation state) methyltransferase show wide variation across multiple populations. Arch. Toxicol. 85, 119-125.
26. Gardner, R. M., Nermell, B., Kippler, M., Grandér, M., Li, L., Ekström, E. C., Rahman, A., Lönnerdal, B., Hoque, A. M., and Vahter, M. (2011). Arsenic methylation efficiency increases during the first trimester of pregnancy independent of folate status. Reprod. Toxicol. 31, 210-218.
27. Gomez-Rubio, P., Meza-Montenegro, M. M., Cantu-Soto, E., and Klimecki, W. T. (2010). Genetic association between intronic variants in AS3MT and arsenic methylation efficiency is focused on a large linkage disequilibrium cluster in chromosome 10. J. Appl. Toxicol. 30, 260-270.
28. Gomez-Rubio, P., Roberge, J., Arendell, L., Harris, R. B., O'Rourke, M. K., Chen, Z., Cantu-Soto, E., Meza-Montenegro, M. M., Billheimer, D., Lu, Z., et al. (2011). Association between body mass index and arsenic methylation efficiency in adult women from southwest U.S. and northwest Mexico. Toxicol. Appl. Pharmacol. 252, 176-182.
29. Gribble, M. O., Howard, B. V., Umans, J. G., Shara, N. M., Francesconi, K. A., Goessler, W., Crainiceanu, C. M., Silbergeld, E. K., Guallar, E., and Navas-Acien, A. (2012). Arsenic exposure, diabetes prevalence, and diabetes control in the Strong Heart Study. Am. J. Epidemiol. 176, 865-874.
30. Hamdi, M., Sanchez, M. A., Beene, L. C., Liu, Q., Landfear, S. M., Rosen, B. P., and Liu, Z. (2009). Arsenic transport by zebrafish aquaglyceroporins. BMC Mol. Biol. 10, 104.
31. Hernández, A., and Marcos, R. (2008). Genetic variations associated with interindividual sensitivity in the response to arsenic exposure. Pharmacogenomics 9, 1113-1132.
32. Hernández, A., Xamena, N., Sekaran, C., Tokunaga, H., Sampayo-Reyes, A., Quinteros, D., Creus, A., and Marcos, R. (2008a). High arsenic metabolic efficiency in AS3MT287Thr allele carriers. Pharmacogenet. Genomics 18, 349-355.
33. Hernández, A., Xamena, N., Surrallés, J., Sekaran, C., Tokunaga, H., Quinteros, D., Creus, A., and Marcos, R. (2008b). Role of the Met(287)Thr polymorphism in the AS3MT gene on the metabolic arsenic profile. Mutat. Res. 637, 80-92.
34. Huang, Y. K., Huang, Y. L., Hsueh, Y. M., Yang, M. H., Wu, M. M., Chen, S. Y., Hsu, L. I., and Chen, C. J. (2008). Arsenic exposure, urinary arsenic speciation, and the incidence of urothelial carcinoma: A twelve-year follow-up study. Cancer Cause Control 19, 829-839.
35. Huang, Y. L., Hsueh, Y. M., Huang, Y. K., Yip, P. K., Yang, M. H., and Chen, C. J. (2009). Urinary arsenic methylation capability and carotid atherosclerosis risk in subjects living in arsenicosis-hyperendemic areas in southwestern Taiwan. Sci. Total Environ. 407, 2608-2614.
36. IARC (2004). Some Drinking-Water Disinfectants and Contaminants, Including Arsenic. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans). IARC, Lyon, France.
37. Kala, S. V., Neely, M. W., Kala, G., Prater, C. I., Atwood, D. W., Rice, J. S., and Lieberman, M. W. (2000). The MRP2/cMOAT transporter and arsenicglutathione complex formation are required for biliary excretion of arsenic. J. Biol. Chem. 275, 33404-33408.
38. Kindla, J., Müller, F., Mieth, M., Fromm, M. F., and König, J. (2011). Influence of non-steroidal anti-inflammatory drugs on organic anion transporting polypeptide (OATP) 1B1-and OATP1B3-mediated drug transport. Drug Metab. Dispos. 39, 1047-1053.
39. Kojima, C., Qu, W., Waalkes, M. P., Himeno, S., and Sakurai, T. (2006). Chronic exposure to methylated arsenicals stimulates arsenic excretion pathways and induces arsenic tolerance in rat liver cells. Toxicol. Sci. 91, 70-81.
40. König, J., Müller, F., and Fromm, M. F. (2013). Transporters and drugdrug interactions: Important determinants of drug disposition and effects. Pharmacol. Rev. 65, 944-966.
41. Lee, E. T., Welty, T. K., Fabsitz, R., Cowan, L. D., Le, N. A., Oopik, A. J., Cucchiara, A. J., Savage, P. J., and Howard, B. V. (1990). The Strong Heart Study. A study of cardiovascular disease in American Indians: Design and methods. Am. J. Epidemiol. 132, 1141-1155.
42. Lee, T. C., Ho, I. C., Lu, W. J., and Huang, J. D. (2006). Enhanced expression of multidrug resistance-associated protein 2 and reduced expression of aquaglyceroporin 3 in an arsenic-resistant human cell line. J. Biol. Chem. 281, 18401-18407.
43. Li, X., Li, B., Xu, Y., Wang, Y., Jin, Y., Itoh, T., Yoshida, T., and Sun, G. (2011). Arsenic methylation capacity and its correlation with skin lesions induced by contaminated drinking water consumption in residents of chronic arsenicosis area. Environ. Toxicol. 26, 118-123.
44. Liu, Z., Shen, J., Carbrey, J. M., Mukhopadhyay, R., Agre, P., and Rosen, B. P. (2002). Arsenite transport by mammalian aquaglyceroporins AQP7 and AQP9. Proc. Natl. Acad. Sci. U.S.A. 99, 6053-6058.
45. Lu, W. J., Tamai, I., Nezu, J., Lai, M. L., and Huang, J. D. (2006). Organic anion transporting polypeptide-C mediates arsenic uptake in HEK-293 cells. J. Biomed. Sci. 13, 525-533.
46. Maull, E. A., Ahsan, H., Edwards, J., Longnecker, M. P., Navas-Acien, A., Pi, J., Silbergeld, E. K., Styblo, M., Tseng, C. H., Thayer, K. A., et al. (2012). Evaluation of the association between arsenic and diabetes: A National Toxicology Program workshop review. Environ. Health Perspect. 120, 1658-1670.
47. McDermott, J. R., Jiang, X., Beene, L. C., Rosen, B. P., and Liu, Z. (2010). Pentavalent methylated arsenicals are substrates of human AQP9. Biometals 23, 119-127.
48. Moon, K., Guallar, E., and Navas-Acien, A. (2012). Arsenic exposure and cardiovascular disease: An updated systematic review. Curr. Atheroscler. Rep. 14, 542-555.
49. Moskvina, V., and Schmidt, K. M. (2008). On multiple-testing correction in genome-wide association studies. Genet. Epidemiol. 32, 567-573.
50. Müller, F., and Fromm, M. F. (2011). Transporter-mediated drug-drug interactions. Pharmacogenomics 12, 1017-1037.
51. Navas-Acien, A., Umans, J. G., Howard, B. V., Goessler, W., Francesconi, K. A., Crainiceanu, C. M., Silbergeld, E. K., and Guallar, E. (2009). Urine arsenic concentrations and species excretion patterns in American Indian communities over a 10-year period: The Strong Heart Study. Environ. Health Perspect. 117, 1428-1433.
52. North, K. E., Howard, B. V., Welty, T. K., Best, L. G., Lee, E. T., Yeh, J. L., Fabsitz, R. R., Roman, M. J., and MacCluer, J. W. (2003). Genetic and environmental contributions to cardiovascular disease risk in American Indians: The strong heart family study. Am. J. Epidemiol. 157, 303-314.
53. Pierce, B. L., Kibriya, M. G., Tong, L., Jasmine, F., Argos, M., Roy, S., Paul-Brutus, R., Rahaman, R., Rakibuz-Zaman, M., Parvez, F., et al. (2012). Genome-wide association study identifies chromosome 10q24.32 variants associated with arsenic metabolism and toxicity phenotypes in Bangladesh. PLoS Genet. 8, e1002522.
54. Scheer, J., Findenig, S., Goessler, W., Francesconi, K. A., Howard, B., Umans, J. G., Pollak, J., Tellez-Plaza, M., Silbergeld, E. K., Guallar, E., et al. (2012). Arsenic species and selected metals in human urine: Validation of HPLC/ ICPMS and ICPMS procedures for a long-term population-based epidemiological study. Anal. Methods 4, 406-413.
55. Smith, A. V. (2008). Browsing HapMap data using the Genome Browser. CSH Protoc. 2008, pdb.prot5023.
56. States, J. C., Barchowsky, A., Cartwright, I. L., Reichard, J. F., Futscher, B. W., and Lantz, R. C. (2011). Arsenic toxicology: Translating between experimental models and human pathology. Environ. Health Perspect. 119, 1356-1363.
57. Tellez-Plaza, M., Gribble, M. O., Voruganti, V. S., Francesconi, K. A., Goessler, W., Umans, J. G., Silbergeld, E. K., Guallar, E., Franceschini, N., North, K. E., et al. (2013). Heritability and preliminary genome-wide linkage analysis of arsenic metabolites in urine. Environ. Health Perspect. 121, 345-351.
58. Thomas, D. J. (2009). Unraveling arsenic-glutathione connections. Toxicol. Sci. 107, 309-311.
59. Thorisson, G. A., Smith, A. V., Krishnan, L., and Stein, L. D. (2005). The International HapMap Project Web site. Genome Res. 15, 1592-1593.
60. Vahter, M., and Concha, G. (2001). Role of metabolism in arsenic toxicity. Pharmacol. Toxicol. 89, 1-5.
61. Villa-Bellosta, R., and Sorribas, V. (2008). Role of rat sodium/phosphate cotransporters in the cell membrane transport of arsenate. Toxicol. Appl. Pharmacol. 232, 125-134.
62. Villa-Bellosta, R., and Sorribas, V. (2010). Arsenate transport by sodium/phosphate cotransporter type IIb. Toxicol. Appl. Pharmacol. 247, 36-40.
63. Voruganti, V. S., Cole, S. A., Ebbesson, S. O., Göring, H. H., Haack, K., Laston, S., Wenger, C. R., Tejero, M. E., Devereux, R. B., Fabsitz, R. R., et al. (2010). Genetic variation in APOJ, LPL, and TNFRSF10B affects plasma fatty acid distribution in Alaskan Eskimos. Am. J. Clin. Nutr. 91, 1574-1583.
64. Wang, C., Chen, G., Jiang, J., Qiu, L., Hosoi, K., and Yao, C. (2009). Aquaglyceroporins are involved in uptake of arsenite into murine gastrointestinal tissues. J. Med. Invest. 56(Suppl), 343-346.
65. Wilke, R. A., Ramsey, L. B., Johnson, S. G., Maxwell, W. D., McLeod, H. L., Voora, D., Krauss, R. M., Roden, D. M., Feng, Q., Cooper-Dehoff, R. M., et al. Clinical Pharmacogenomics Implementation Consortium (CPIC). (2012). The clinical pharmacogenomics implementation consortium: CPIC guideline for SLCO1B1 and simvastatin-induced myopathy. Clin. Pharmacol. Ther. 92, 112-117.
66. Wood, T. C., Salavagionne, O. E., Mukherjee, B., Wang, L., Klumpp, A. F., Thomae, B. A., Eckloff, B. W., Schaid, D. J., Wieben, E. D., and Weinshilboum, R. M. (2006). Human arsenic methyltransferase (AS3MT) pharmacogenetics: Gene resequencing and functional genomics studies. J. Biol. Chem. 281, 7364-7373.
67. Xie, Y., Liu, J., Liu, Y., Klaassen, C. D., and Waalkes, M. P. (2004). Toxicokinetic and genomic analysis of chronic arsenic exposure in multidrug-resistance mdr1a/1b(-/-) double knockout mice. Mol. Cell. Biochem. 255, 11-18.
68. Zhao, F. J., Ago, Y., Mitani, N., Li, R. Y., Su, Y. H., Yamaji, N., McGrath, S. P., and Ma, J. F. (2010). The role of the rice aquaporin Lsi1 in arsenite efflux from roots. New Phytol. 186, 392-399.